Abstract
Objective: To test the prevalences and the clinical associations of anticardiolipin (aCL) and anti-β2GPI (aβ2GPI) antibodies in a large series of European patients with systemic lupus erythematosus (SLE). Methods: 574 SLE patients from 7 European countries were tested for aCL and aβ2GPI by ELISA methods. Results: aCL of IgG, IgM, and IgA isotypes were detected in 22.8%, 14%, and 13.9% of the patients, respectively. IgG and IgM aβ2GPI were detected in 20% of the patients. The presence of aCL was highly associated with the presence of aβ2GPI. Medium-high titer IgG aCL and aβ2GPI were associated with thrombosis, with similar sensitivity, specificity, and positive predictive value. When present at medium-high titer, IgG aCL were associated with thrombocytopenia, IgM aCL with hemolytic anemia, and cerebrovascular accidents, IgA aCL with livedo reticularis and Raynaud's phenomenon. Conclusions: aCL, when present at medium-high titer, are as important as aβ2GPI, as a risk factor for thrombosis. Medium-high titer aCL, but not aβ2GPI, are associated with other clinical features of the antiphospholipid syndrome.
| Original language | English |
|---|---|
| Pages (from-to) | 344-351 |
| Number of pages | 8 |
| Journal | Scandinavian Journal of Rheumatology |
| Volume | 28 |
| Issue number | 6 |
| Publication status | Published - 1999 |
Fingerprint
Keywords
- aβGPI
- aCL
- Antiphospholipid syndrome
- Systemic lupus erythematosus
ASJC Scopus subject areas
- Immunology
- Rheumatology
Cite this
Anticardiolipin and anti-β2GPI antibodies in a large series of European patients with systemic lupus erythematosus. / Sebastiani, Gian Domenico; Galeazzi, Mauro; Tincani, Angela; Piette, Jean Charles; Font, Josep; Allegri, Flavio; Mathieu, Alessandro; Smolen, Josef; De Ramon Garrido, Enrique; Fernandez-Nebro, Antonio; Jedryka-Goral, Anna; Papasteriades, Chryssa; Morozzi, Gabriella; Bellisai, Francesca; De Pita, Ornella; Marcolongo, Roberto.
In: Scandinavian Journal of Rheumatology, Vol. 28, No. 6, 1999, p. 344-351.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Anticardiolipin and anti-β2GPI antibodies in a large series of European patients with systemic lupus erythematosus
AU - Sebastiani, Gian Domenico
AU - Galeazzi, Mauro
AU - Tincani, Angela
AU - Piette, Jean Charles
AU - Font, Josep
AU - Allegri, Flavio
AU - Mathieu, Alessandro
AU - Smolen, Josef
AU - De Ramon Garrido, Enrique
AU - Fernandez-Nebro, Antonio
AU - Jedryka-Goral, Anna
AU - Papasteriades, Chryssa
AU - Morozzi, Gabriella
AU - Bellisai, Francesca
AU - De Pita, Ornella
AU - Marcolongo, Roberto
PY - 1999
Y1 - 1999
N2 - Objective: To test the prevalences and the clinical associations of anticardiolipin (aCL) and anti-β2GPI (aβ2GPI) antibodies in a large series of European patients with systemic lupus erythematosus (SLE). Methods: 574 SLE patients from 7 European countries were tested for aCL and aβ2GPI by ELISA methods. Results: aCL of IgG, IgM, and IgA isotypes were detected in 22.8%, 14%, and 13.9% of the patients, respectively. IgG and IgM aβ2GPI were detected in 20% of the patients. The presence of aCL was highly associated with the presence of aβ2GPI. Medium-high titer IgG aCL and aβ2GPI were associated with thrombosis, with similar sensitivity, specificity, and positive predictive value. When present at medium-high titer, IgG aCL were associated with thrombocytopenia, IgM aCL with hemolytic anemia, and cerebrovascular accidents, IgA aCL with livedo reticularis and Raynaud's phenomenon. Conclusions: aCL, when present at medium-high titer, are as important as aβ2GPI, as a risk factor for thrombosis. Medium-high titer aCL, but not aβ2GPI, are associated with other clinical features of the antiphospholipid syndrome.
AB - Objective: To test the prevalences and the clinical associations of anticardiolipin (aCL) and anti-β2GPI (aβ2GPI) antibodies in a large series of European patients with systemic lupus erythematosus (SLE). Methods: 574 SLE patients from 7 European countries were tested for aCL and aβ2GPI by ELISA methods. Results: aCL of IgG, IgM, and IgA isotypes were detected in 22.8%, 14%, and 13.9% of the patients, respectively. IgG and IgM aβ2GPI were detected in 20% of the patients. The presence of aCL was highly associated with the presence of aβ2GPI. Medium-high titer IgG aCL and aβ2GPI were associated with thrombosis, with similar sensitivity, specificity, and positive predictive value. When present at medium-high titer, IgG aCL were associated with thrombocytopenia, IgM aCL with hemolytic anemia, and cerebrovascular accidents, IgA aCL with livedo reticularis and Raynaud's phenomenon. Conclusions: aCL, when present at medium-high titer, are as important as aβ2GPI, as a risk factor for thrombosis. Medium-high titer aCL, but not aβ2GPI, are associated with other clinical features of the antiphospholipid syndrome.
KW - aβGPI
KW - aCL
KW - Antiphospholipid syndrome
KW - Systemic lupus erythematosus
UR - http://www.scopus.com/inward/record.url?scp=0033256156&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033256156&partnerID=8YFLogxK
M3 - Article
C2 - 10665739
AN - SCOPUS:0033256156
VL - 28
SP - 344
EP - 351
JO - Scandinavian Journal of Rheumatology
JF - Scandinavian Journal of Rheumatology
SN - 0300-9742
IS - 6
ER -